Group A meningococcal vaccination: routine programme needed Newsletter Article 15 February 2013 Pages: 3 - 3
Dual protease inhibitor therapy an ‘attractive’ option Newsletter Article 15 February 2013 Pages: 4 - 4
Missed opportunities for estrogen replacement therapy Newsletter Article 15 February 2013 Pages: 4 - 4
Societal costs similar with clozapine and haloperidol Newsletter Article 15 February 2013 Pages: 5 - 5
Multicentre QOL study highlights need for better antimigraine therapy Newsletter Article 15 February 2013 Pages: 6 - 6
Widespread antibacterial use in colds, URTIs and bronchitis Newsletter Article 15 February 2013 Pages: 6 - 6
New data on GPIIb/IIIa receptor antagonist use in unstable angina Gill Higgins Newsletter Article 15 February 2013 Pages: 7 - 8
Indinavir and once-daily DMP-266 effective in HIV infection Newsletter Article 15 February 2013 Pages: 9 - 9
Propentofylline: ‘positive therapeutic effects’ in dementia Newsletter Article 15 February 2013 Pages: 9 - 9
Filgrastim improves outcome of diabetic foot infection Newsletter Article 15 February 2013 Pages: 10 - 10
Chemoradiation therapy promising for cervical cancer Newsletter Article 15 February 2013 Pages: 10 - 10
Alendronic acid: benefits in prevention and treatment of PMO Larry Prescott Newsletter Article 15 February 2013 Pages: 11 - 12
Adjunctive dexamethasone beneficial in bacterial meningitis Newsletter Article 15 February 2013 Pages: 13 - 13
Formestane: 250mg vs 500mg in relapsed breast cancer Newsletter Article 15 February 2013 Pages: 13 - 13
High-dose chemotherapy + stem cells promising in breast cancer Newsletter Article 15 February 2013 Pages: 14 - 14
Cyclical etidronic acid prevents early postmenopausal bone loss Newsletter Article 15 February 2013 Pages: 14 - 14
Topical finasteride beneficial in androgenic alopecia Newsletter Article 15 February 2013 Pages: 15 - 15
No increase in incidence of malaria with iron supplementation Newsletter Article 15 February 2013 Pages: 15 - 15
Molgramostim + cytotoxics double survival time in sarcoma Newsletter Article 15 February 2013 Pages: 16 - 16
Growth hormone: genetic growth potential not restored Newsletter Article 15 February 2013 Pages: 16 - 16
TB prophylaxis beneficial in Ugandan patients with HIV Newsletter Article 15 February 2013 Pages: 17 - 17
Varicella vaccine reduces herpes zoster severity after BMT … Newsletter Article 15 February 2013 Pages: 18 - 18
… and may be beneficial in paediatric BMT recipients Newsletter Article 15 February 2013 Pages: 18 - 18
DTPa-IPV and Hib vaccines can be mixed & administered together Newsletter Article 15 February 2013 Pages: 19 - 19
ADR reporting in Eastern Europe coming into line with EU? Pauline Curel Newsletter Article 15 February 2013 Pages: 20 - 21
NSAIDs and necrotising soft tissue infections: FDA reviews case reports Newsletter Article 15 February 2013 Pages: 21 - 21
Fenfluramine and dexfenfluramine withdrawn from market Newsletter Article 15 February 2013 Pages: 22 - 22